68 results about "Respiration Disorders" patented technology

A pharmaceutical composition and formulations comprise preventative, prophylactic or therapeutic amounts of an oligo(s) anti-sense to a specific gene(s) or its corresponding mRNA(s), and a glucocorticoid and/or non-glucocorticoid steroid or a ubiquinone or their salts. The agents, composition and formulations are used for treatment of ailments associated with impaired respiration, bronchoconstriction, lung allergy(ies) or inflammation, and abnormal levels of adenosine, adenosine receptors, sensitivity to adenosine, lung surfactant and ubiquinone, such as pulmonary fibrosis, vasoconstriction, inflammation, allergies, allergic rhinitis, asthma, impeded respiration, lung pain, cystic fibrosis, bronchoconstriction, COPD, RDS, ARDS, cancer, and others. The present treatment is effectively administered by itself for conditions without known therapies, as a substitute for therapies exhibiting undesirable side effects, or in combination with other treatments, e.g. before, during and after other respiratory system therapies, radiation, chemotherapy, antibody therapy and surgery, among others. Each of the agents of this invention may be administered directly into the respiratory system so that they gain direct access to the lungs, or by other effective routes of administration. A kit comprises a delivery device, the agents and instructions for its use.

A therapy system adapted to treat a patient's ventilatory instability using a ventilatory therapy, a gas modulation therapy, or both. The algorithm implemented by the therapy system monitors the ventilatory instability, such as Cheyne Stokes Respiration (CSR), mixed apneas, CPAP emergent apneas, and complex sleep disordered breathing (CSDB) and treats the ventilatory instability. The algorithm also determine a reference point with respect to the ventilatory instability. The therapy delivery system initiate the treatment based on the reference point.

An apnea/hypopnea detection system and method that monitors a patient's respiratory flow, determines (a) a long term RMS energy based on the flow, (b) a long term threshold determined based on the long term RMS energy, and (c) a short term RMS energy based on the flow. Determining whether the patient is experiencing an apnea/hypopnea is accomplished by comparing the short term RMS energy with the long term threshold. This A/H detection technique is useful in diagnosing a patient for a breathing disorder, such as OSA, and/or for controlling an auto-titration pressure support system.

A system and method are disclosed for the provision of assisted breathing by the delivery of a controlled pressurized Airflow to the pulmonary airway of a user with breathing disorders. The system comprises a source of compressed respiratory gas (112), a user interface unit (115) including at least one Venturi device (120) and a thin flexible tubing (116) connecting between the source of high pressure gas (112) and the Venturi device. The system and method provide a regulated and controlled flow of air to the user (105) in accordance with the user needs. The invention further discloses a novel small light-weight user interface for replacing prior art breathing masks.

Methods and systems for diagnosing disorders, including, for example, disordered breathing, involve sensing one or more of a blood chemistry parameter and/or an expired gas parameter, such as expired respiratory gas concentration, blood gas concentration, and blood pH. Diagnosis of the disorder may be performed by a medical device, such as a respiratory therapy device or a cardiac therapy device, based on implantably detected blood gas/pH concentration/level or externally detected expired respiratory gas concentration. Cardiac and respiratory therapies for addressing the disorder may be adjusted based on the detected parameters.

A ventilator for supplying breathable gas to the airway of a patient with a respiratory disorder is provided herein an, in one embodiment, includes a gas flow generator for generating a flow of said breathable gas to the patient, said gas flow generator comprising a gas flow generator chamber provided with a gas inlet opening and a gas outlet opening; a control valve for controlling the flow and/or pressure of the gas distributed to the patient, said control valve comprising a valve body which is rotatably arranged about a rotational axis within a valve chamber. The valve body essentially exhibits the shape of a sector of a circle, in such a way that an arced first flow regulatory surface is formed along the circular arc of said sector, and that second and third essentially straight flow regulatory surfaces, respectively, are formed along the two diverging sides of said sector.

The invention relates the sensing device used to check sleeping state and interference with respiration. The device comprises spring mattress 1, and pressure sensing device. The spring mattress 1 comprises at least two vent longitudinal partition cushion (11, 12, 13, 14), the adjacent side walls (11a, 12a) are near, the bottoms of cushions(11b, 12b) are connected with each other, the sensing device is sealed elastic body(21, 22) with fluid, in the elastic body there is sensing elements(21a, 22a), the output end of sensing elements are connected with data processing device by wires, and the sealed elastic body(21, 22) is installed on the mattress. The invention improves the comfort degree and sensibility.

The invention belongs to the technical field of biological detection and relates to an African swine fever polymerase chain reaction (PCR) detection method and an oligonucleotide primer pair. The method comprises the following steps: designing a pair of specific primers by referring to a complete genome sequence of 23 ASFVP72 protein strains recorded in GenBank, exploring the optimal reaction system and reaction conditions according to the designed primers, performing sensitivity test, specificity test and reproducibility test on the established PCR reaction method, and performing PCR method detection on clinical samples of sows suffered from reproductive disturbance or piglets with respiratory disturbance symptoms and aborted fetuses from 14 pig farms. The test results prove that the established PCR method can sensitively and rapidly detect the African swine fever virus. The PCR detection method established in the research has high applicability and can be used for detecting the African swine fever disease.

The invention provides anintelligent abdominal breathing physical therapy training instrument. The instrument can assist abdominal breathing practice of patients with a respiratory disorder and a congenital respiratory disease through the arrangement of a breathing assisting device and a suction cup so that the patientswith the respiratory disorder and congenital respiratory diseasecan perform deep abdominal breathing to help the patients breathe deeply, which is beneficial to the prevention and treatment of lung and respiratory diseases. Moreover, the instrument is conveniently worn by a userto perform the abdominal breathing practice anytime and anywhere, has an intelligent control system and an intelligent interactive display device to provide reasonable guidance for the user to use, is suitable for respiratory function training programs of the useraccording to an actual situation, achieves the intelligent and efficient respiratory physical therapy training effect, monitors the accuracy of the abdominal breathing practice during the use of the user by setting an abdominal breathing detection device in the chest position of a human body, and avoids the invalid abdominal breathing practice.

The present invention relates to a new Chinese Tibetan medicine-chongcao qingfei capsule with the functions of moistening lung, supplementing qi, relieving cough and asthma for curing pulmonary diseases of acute and chronic bronchitis, pulmonary emphysema, pneumoconiosis, tabacosis pulmonum and pneumosilicosis, etc. Said new type Chinese Tibetan medicine is made up by using 100 traditional Chinese Tibetan medicinal materials of stemona root, bletilla tuber, oyster shell and others through a certain preparation process.

The invention discloses a sleep respiratory disorder treatment system. The system comprises a physiological signal acquisition unit, a physiological signal processing unit, an electrical stimulation parameter control unit, an electrical stimulation unit and a treatment effect statistics and display unit, wherein the units are connected wirelessly or wiredly; electric stimulation parameters are automatically adjusted according to individual physiological signal feedback of each user. According to the system, sleep apnea, hypopnea and snoring symptoms can be effectively eliminated or relieved through percutaneous current stimulation under the condition that the sleep state of the users is not disturbed; an accurate medical effect is obtained; the use compliance of patients is improved.

An ambulatory assist ventilation (AAV) apparatus and system are disclosed for the delivery of a respiratory gas to assist the spontaneous breathing effort of a patient with a breathing disorder. The AAV system includes a compressed respiratory gas source, a respiratory assist device for controlling respiratory gas flow to the patient, a patient circuit tubing and a low profile nasal interface device, which does not have a dead space or hollow area where CO2 can collect, for delivering the respiratory gas to the patient, wherein the nasal interface device is fluidly connected to the respiratory assist device via tubing for receiving the respiratory gas therefrom. In some cases, the nasal interface device may be used in combination with other gas sources, such as oxygen concentrators, to provide dual therapy capability suitable for some applications.

The invention belongs to the technical field of medicine, and in particular, relates to a use of beta-nicotinamide mononucleotide or a precursor thereof in preparation of medicines or health productsfor treating or alleviating respiratory disorders or diseases. The technical problem to be solved by the invention comprises that a new alternative scheme is provided for preparation of the medicinesor health products for treating or alleviating the respiratory disorders or diseases, and the technical scheme for solving the technical problem comprises that provided is the use of the beta-nicotinamide mononucleotide or the precursor thereof in preparation of the medicines or health products for treating or alleviating the respiratory disorders or diseases. The beta-nicotinamide mononucleotideor beta-nicotinamide riboside can effectively treat pulmonary diseases such as chronic obstructive pulmonary disease, can significantly alleviate the aging of pulmonary macrophages caused by inhalablegranules, and has a good application prospect.

The invention relates to a traditional Chinese veterinary medicine compound preparation Shuanghuanglian for injection as well as a preparation technology and an application thereof. The compound preparation comprises the components in parts by weight as follows: 1300-1700 parts of honeysuckle, 1300-3700 parts of radix scutellariae and 2500-7500 parts of fructus forsythiae. Slow-release accessories comprise 150 parts of hydroxymethyl propyl cellulose and 100 parts of sodium carboxymethyl cellulose. The compound preparation contains the slow-release accessories, so that the injection time of large animals can be reduced, and the stress response of the large animals can be reduced. The traditional Chinese veterinary medicine compound preparation for injection has antiviral, antibacterial, anti-inflammatory, antipyretic, analgesic, immunity-improving effects and the like. Veterinarian clinic proves that the compound preparation can be used for treating epidemic diarrhea; transmissible gastroenteritis; necrotic enteritis; septicemia caused by various epidemic diseases; cough, dyspnea, skin cyanosis, arthrocele which are caused by chromic respiratory diseases such as streptococcosis, haemophflussuis, contagious porcine pleuropneumonia, swine plague and the like; and porcine reproductive and respiratory syndrome and cow mastitis.

The invention discloses a device for detecting obstructive respiration disorder. The device comprises an acceleration sensor, an analog signal pre-processing circuit, an A/D converter, a skin resistance sensor and a single chip, wherein the analog signal pre-processing circuit comprises an analog signal amplifying circuit and an analog signal filter circuit; the acceleration sensor is used for acquiring a respiratory movement analog signal of a human body chest/abdomen part under a sleep status; the skin resistance sensor is used for acquiring a skin resistance signal of the chest/abdomen part; the A/D converter is used for converting the respiratory movement analog signal, which is processed by virtue of the analog signal pre-processing circuit, into a digital signal; the single chip is used for conducting obstructive respiration disorder judgment in accordance with the skin resistance signal and the digital signal; and the single chip is connected to the A/D converter and the skin resistance sensor. The invention also discloses a testing method based on the device for detecting the obstructive respiration disorder. According to the device and the testing method provided by the invention, under the precondition of guaranteeing detection accuracy, cost is also reduced.

A molded breathing appliance for supporting a nasal oxygen tube having an upper bite rim, a lower bite rim, a moldable material disposed within the upper bite rim and lower bite rim for conforming to a patient's maxillary bite impression and mandibular bite impression, respectively, an L-shaped member extending outwardly perpendicular to the upper bite rim, and a transverse support disposed on the L-shaped member and configured with a plurality of sets of oxygen tube finger clamps to retain a nasal oxygen tube in proximity with a patient's nostrils.